SAN DIEGO, CA, Amprion, a global leader advancing diagnoses of neurodegenerative disorders, announced the successful initial $6 million close of a $15 million Series B financing, led by Formation Venture Engineering.
Amprion, a global leader advancing diagnoses of neurodegenerative disorders, announced the successful initial $6 million close of a $15 million Series B financing. The round was led by Formation Venture Engineering (FVE) with participation by Eli Lilly and Company and Amprion's Series A investors. It will expand Amprion's commercial reach and enable increased R&D investment to further Amprion's mission to revolutionize brain disease diagnosis.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
